Pavitra S. Ramachandran, Ph.D.
Affiliations: | 2014 | Genetics | University of Iowa, Iowa City, IA |
Google:
"Pavitra Ramachandran"Mean distance: 17811
Parents
Sign in to add mentor| Beverly L. Davidson | grad student | 2014 | University of Iowa | |
| (RNA interference therapy for the spinocerebellar ataxias.) | ||||
| Jean Bennett | post-doc | 2014-2017 | Penn (Cell & Gene Therapy Tree) | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Nikonov S, Aravand P, Lyubarsky A, et al. (2022) Restoration of Vision and Retinal Responses After Adeno-Associated Virus-Mediated Optogenetic Therapy in Blind Dogs. Translational Vision Science & Technology. 11: 24 |
| Duong TT, Vasireddy V, Ramachandran P, et al. (2018) Use of induced pluripotent stem cell models to probe the pathogenesis of Choroideremia and to develop a potential treatment. Stem Cell Research. 27: 140-150 |
| Aravand P, Ramachandran PS, Schpylchak I, et al. (2017) Protocols for Visually Guided Navigation Assessment of Efficacy of Retina-Directed Cell or Gene Therapy in Canines. Frontiers in Neuroscience. 11: 215 |
| Ramachandran P, Lee V, Wei Z, et al. (2016) Evaluation of dose and safety of AAV7m8 and AAV8BP2 in the non-human primate retina. Human Gene Therapy |
| Ramachandran PS, Nikonov S, Willett K, et al. (2016) 270. Optogenetic Activation of Remnant Cone Cells Can Restore Ganglion Cell Light Responses in a Canine Model of Retinitis Pigmentosa Molecular Therapy. 24: S107 |
| Leung A, Hua K, Ramachandran P, et al. (2015) C. elegans HAM-1 functions in the nucleus to regulate asymmetric neuroblast division. Developmental Biology |
| Ramachandran PS, Song JY, Bennett J. (2015) Exploiting metabolic and antioxidant pathways to maintain vision in blinding disease. The Journal of Clinical Investigation. 125: 1390-2 |
| Ramachandran PS, Boudreau RL, Schaefer KA, et al. (2014) Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1635-42 |
| Ramachandran PS, Bhattarai S, Singh P, et al. (2014) RNA interference-based therapy for spinocerebellar ataxia type 7 retinal degeneration. Plos One. 9: e95362 |
| Ramachandran PS, Keiser MS, Davidson BL. (2013) Recent advances in RNA interference therapeutics for CNS diseases. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 10: 473-85 |